Stelara for Psoriasis

Filed Under (Drug News) by David on 07-12-2009

0

StelaraUstekinumab (Stelara, Centocor Ortho Biotech Inc.), a biologic agent, has been approved for adults with moderate-to-severe psoriasis, an immune system disorder that results in the rapid over-production of skin cells. Plaque psoriasis is characterized by thickened patches of inflamed, red skin, often covered with silvery scales.

Read the rest of this entry »